Diligence · Healthcare Services

Regulatory Diligence for Healthcare Services Independent Sponsors

Independent sponsor counsel for healthcare services, focused on Regulatory Diligence and the deal mechanics that protect sponsor economics and LP alignment.

EV range $15M to $120M EV EBITDA $3M to $20M Audience Buy-side / Sponsor
The deal context

Every healthcare services acquisition has its own gravity. Regulatory Diligence is the workstream where independent sponsor counsel earns the seat.

The typical healthcare services platform sits at $15M to $120M EV with EBITDA in the $3M to $20M range. The thesis runs on roll-up of physician practices and ancillary service lines. Most off-market healthcare deals come through advisors who have seen the structure before. Have one in your call list.

The moves

How Regulatory Diligence actually gets structured.

  1. Map every license and permit, with renewal dates and transfer mechanics.

  2. Identify regulatory consent requirements that require pre-close filings.

  3. Address pending or threatened regulatory actions in the disclosure schedules.

  4. Plan the post-close regulatory calendar with the operating team.

  5. In healthcare services, layer in PC/MSO structuring as part of the Regulatory Diligence workstream.

The common mistake

Treating regulatory diligence as a sub-section. In regulated industries, it is the whole deal.

Jason's take
"Regulatory continuity is the closing condition that fails most often. Diligence it first, not last."
Jason Powell · Regulatory Diligence
Capital after close

The deal is one thing. The capital that opens up after close is another.

The capital that opens up post-close, from refinancing to growth equity to strategic exit, runs through a small set of Wall Street relationships. That network is built in.

MONTH 18
Senior refi
MONTH 24
Dividend recap
MONTH 36
Growth equity
YEAR 4–5
Strategic exit
TALK TO JASON

An LOI on the desk, a healthcare services target, and a Regulatory Diligence question worth a real conversation.

Twenty minutes of practitioner-grade input from a securities attorney whose first move is to read the deal, not the engagement letter.